| Literature DB >> 32208265 |
Ayesha Sarfraz1, Maria Javeed1, Muhammad Ajmal Shah2, Ghulam Hussain3, Nusrat Shafiq4, Iqra Sarfraz1, Ammara Riaz1, Ayesha Sadiqa1, Rabia Zara1, Saba Zafar1, Lubna Kanwal5, Satyajit D Sarker6, Azhar Rasul7.
Abstract
Natural products (NPs) will continue to serve humans as matchless source of novel drug leads and an inspiration for the synthesis of non-natural drugs. As our scientific understanding of 'nature' is rapidly expanding, it would be worthwhile to illuminate the pharmacological distinctions of NPs to the scientific community and the public. Flavonoids have long fascinated scientists with their remarkable structural diversity as well as biological functions. Consequently, this review aims to shed light on the sources and pharmacological significance of a dietary isoflavone, biochanin A, which has been recently emerged as a multitargeted and multifunctional guardian of human health. Biochanin A possesses anti-inflammatory, anticancer, neuroprotective, antioxidant, anti-microbial, and hepatoprotective properties. It combats cancer development by inducing apoptosis, inhibition of metastasis and arresting cell cycle via targeting several deregulated signaling pathways of cancer. It fights inflammation by blocking the expression and activity of pro-inflammatory cytokines via modulation of NF-κB and MAPKs. Biochanin A acts as a neuroprotective agent by inhibiting microglial activation and apoptosis of neurons. As biochanin A has potential to modulate several biological networks, thus, it can be anticipated that this therapeutically potent compound might serve as a novel lead for drug development in the near future.Entities:
Keywords: Anti-inflammatory; Anti-microbial; Anticancer; Antioxidant; Biochanin A; Isoflavone; Neuroprotective
Mesh:
Substances:
Year: 2020 PMID: 32208265 DOI: 10.1016/j.scitotenv.2020.137907
Source DB: PubMed Journal: Sci Total Environ ISSN: 0048-9697 Impact factor: 7.963